ELOCTATE 500

Země: Izrael

Jazyk: angličtina

Zdroj: Ministry of Health

Aktivní složka:

COAGULATION FACTOR VIII

Dostupné s:

SANOFI - AVENTIS ISRAEL LTD

ATC kód:

B02BD05

Léková forma:

POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Složení:

COAGULATION FACTOR VIII 500 IU

Podání:

I.V

Druh předpisu:

Required

Výrobce:

BIOGEN IDEC LIMITED , UK

Terapeutické oblasti:

COAGULATION FACTOR VII

Terapeutické indikace:

ELOCTATE [Antihemophilic Factor (Recombinant Fc Fusion Protein)] is a long-acting antihemophilic factor (recombinant) indicated in adults and children 12 years of age and older with Hemophilia A (congenital factor VIII deficiency) for:• Control and prevention of bleeding episodes.• Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.• Perioperative management (surgical prophylaxis).ELOCTATE is not indicated for the treatment of von Willebrand disease.

Datum autorizace:

2017-01-09